Dalal Anupam's Form 4/A amendment
AmendedWhitehawk Therapeutics, Inc. (WHWK) · filed Aug 31, 2021
- Accession no.
- 0000899243-21-034635
- Filed
- Aug 31, 2021
- Trade date
- Aug 26, 2021
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Aug 30, 2021
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $20.0M. It was filed 5 days after the trade.
This amendment replaces 0000899243-21-034546 (filed Aug 30, 2021).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dalal AnupamCIK 0001602474 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2021 | Common Stock | PPurchaseAcquired | +1,529,402 | $13.08 | +$20,004,578.16 | 1,529,402 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.